CytoSorbents Devices Wins Emergency Approval to Treat COVID-19 Patients
The Food and Drug Administration says it granted Emergency Use Authorization for CytoSorbent’s (NASDAQ:CTSO) CytoSorb device to treat patients with confirmed Covid-19 admitted to the ICU with confirmed or imminent respiratory failure.
Compassionate Use of Remdesivir for Patients with Severe Covid-19
We provided remdesivir on a compassionate-use basis to patients hospitalized with Covid-19, the illness caused by infection with SARS-CoV-2.
Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19
We describe a patient with Covid-19 and clinically significant coagulopathy, antiphospholipid antibodies, and multiple infarcts. He was one of three patients with these findings in an intensive care unit designated for patients with Covid-19.
Scavenging Gas Outlet Ports with COVID-19 ECMO and new FDA Recommendations for ECMO
The use of vacuum on the gas outlet port of a membrane oxygenator is a safe practice, if done using vacuum <10 mmHg and tubing with an open leur connector, open wye connector or a cut in the vacuum tubing. It is also advisable to turn the vacuum source off when there is no gas flow through the membrane oxygenator.
Leiters Press Release COVID-19
Leiters, a trusted FDA-registered 503B outsourcing provider of high-quality compounded sterile preparations, continues to closely monitor the evolving COVID-19 situation and the potential healthcare drug shortages.
Enforcement Policy for Extracorporeal Membrane Oxygenation and Cardiopulmonary Bypass Devices During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency
The Food and Drug Administration (FDA or Agency) plays a critical role in protecting the United States from threats such as emerging infectious diseases, including the Coronavirus Disease 2019 (COVID-19) pandemic. FDA is committed to providing timely guidance to support response efforts to this pandemic.
Sanibel Symposium 2020 Live Webcast with COVID-19 Content
This year's Sanibel Symposium have special focus on COVID-19 with experts from around the world presenting their experiences and suggestions.
ECMO for COVID19 in Japan
Current situation of ECMO use in Japan for COVID-19 associated ARDS: second ELSO webinar focused on the use of ECLS during the SARS-CoV-2 pandemics, run on March 30th.
ECMO in COVID19: The Power of Connection
The power of connection: at a time when social distancing is a universal necessity, connecting as a healthcare community has never been so vitally important to keeping our patients & colleagues safe.
Vendor Terms and Conditions
Purchase Orders (“PO”) submitted to Vendor by Perfusion.com, Inc. (“PDC”) are subject to the following terms and conditions which Vendor is deemed […]
Leiters Partners with Hibernation Therapeutics to Provide Adenocaine™ Cardioplegic Solution
Leiters, a trusted FDA-registered 503B provider of high-quality compounded sterile preparations, announced today that it has entered into a national agreement with Hibernation Therapeutics to provide a patented cardioplegic solution developed by Hibernation Therapeutics known as Adenocaine™.